Authors’ Reply to Kamel et al.: “Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study”
Crossref DOI link: https://doi.org/10.1007/s40262-016-0493-1
Published Online: 2016-12-27
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Glund, Stephan http://orcid.org/0000-0003-4582-3679
Reilly, Paul
van Ryn, Joanne
Stangier, Joachim
License valid from 2016-12-27